SCHEDULE: Inventiva S.A. Sees Eventide Stake Drop Below 5%

Eventide Asset Management and associated individuals have reduced their beneficial ownership in Inventiva S.A. to 4.6% as of December 31, 2025.

Summary

• Eventide Asset Management, LLC, along with Finny Kuruvilla, M.D., Ph.D., and Robin C. John, reported a beneficial ownership of 9,368,517 Ordinary Shares in Inventiva S.A.
• This represents 4.6% of Inventiva S.A.'s outstanding Ordinary Shares.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating a change from a previous filing where their ownership was likely 5% or more.
• Eventide Asset Management, LLC holds sole voting and dispositive power over all 9,368,517 shares.
• Finny Kuruvilla and Robin C. John share voting and dispositive power over the same 9,368,517 shares.
• The reporting persons certified that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a moderately negative development, as a significant institutional investor has reduced its stake below the 5% threshold, which could signal decreased confidence or a strategic portfolio adjustment.

Positives

• Reporting persons certified that the securities were not acquired or held for the purpose of changing or influencing control of Inventiva S.A., indicating a passive investment strategy.

Negatives

• Beneficial ownership by Eventide Asset Management, LLC and associated individuals has decreased to 4.6% of Inventiva S.A.'s Ordinary Shares, falling below the 5% threshold.

Industry Context

StockSavvy.ai notes that institutional ownership changes, especially reductions below key thresholds like 5%, are closely watched by the market as they can reflect shifts in investor sentiment or strategy regarding a company or sector. For Inventiva S.A., a biotechnology or pharmaceutical company (implied by 'Inventiva S.A.' and common for companies with this structure), such a reduction by an asset management firm could be a signal, though the specific reasons are not disclosed in a 13G.

Comparison to Industry Standards

• Institutional investors typically maintain positions above 5% when they have a strong conviction or strategic interest, triggering Schedule 13G filings. A reduction below this threshold, as seen with Eventide's stake in Inventiva S.A., is a common portfolio management action.
• For example, a similar reduction by a major asset manager in a biotech peer like Moderna or Pfizer might also be interpreted as a strategic rebalancing rather than a fundamental negative, depending on the broader market and company-specific news.

Stakeholder Impact

• Shareholders: May interpret the reduction in institutional ownership as a negative signal, potentially leading to increased selling pressure or a re-evaluation of the stock's prospects.
• Management: Might need to address investor concerns regarding the reduction in institutional support, though the filing itself states the holding is not for control purposes.

Key Dates

Recommendation

The reduction of a significant institutional stake below the 5% threshold, as indicated by this Amendment No. 2, suggests a lack of conviction or a strategic divestment by a major investor. While the filing states the purpose is not to influence control, the market often interprets such a move as a negative signal, potentially leading to downward pressure on the stock price. A seasoned investor would likely view this as a reason to reduce or exit their position, anticipating potential negative sentiment and price action.

Keywords

Inventiva S.A., Eventide Asset Management, Schedule 13G, beneficial ownership, institutional ownership, F5R343107, Ordinary Shares, stock ownership